Roche Canada is a pioneering healthcare brand that has been dedicated to improving lives since its establishment in 1896. With a focus on innovation, Roche develops innovative medicines and diagnostic tests that benefit millions of patients worldwide. As a frontrunner in personalized healthcare, Roche was among the first companies to offer targeted treatments to patients.

With a strong presence in pharmaceuticals and diagnostics, Roche is uniquely positioned to drive personalized healthcare initiatives. Notably, two-thirds of their Research and Development projects are underway with companion diagnostics. Roche is the largest biotech company globally, with 14 biopharmaceuticals currently on the market.

Over 50% of their product pipeline consists of biopharmaceuticals, enabling the delivery of better-targeted therapies. As a leader in cancer treatments for over 50 years, Roche develops medicines for various types of cancer, including breast, skin, colon, ovarian, and lung cancer. Furthermore, Roche is a leading provider of in vitro diagnostics, offering comprehensive information for treatment decisions and addressing patients' concerns.

They strive for innovation and invest approximately 9 billion Swiss francs annually in Research and Development. With a workforce of over 88,000 individuals across more than 150 countries, Roche maintains a reputation as a preferred employer. They have also been consistently recognized as an industry leader in sustainability.

Discover the future of healthcare with Roche Canada